Controlling glycopeptide-resistant enterococci

Clinical Microbiology and Infection

Volumn 3, Issue 1, 1997, Pages 7-11

  Chadwick, Paul R ^a   Oppenheim, Beryl A ^b  

^a HOPE HOSPITAL   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

BACTERIAL COLONIZATION; BACTERIAL INFECTION; ENTEROCOCCUS; INFECTION CONTROL; PRIORITY JOURNAL; REVIEW; SCREENING;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS;

EID: 0030947070     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.1997.tb00244.x     Document Type: Review

References (44)

1. Uttley AHC, George RC, Naidoo J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989; 103: 173-81.
2. Noble WC, Virani Z, Cree R. Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett 1992; 93: 195-8.
3. Bates J, Jordens JZ, Griffiths DT. Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J Antimicrob Chemother 1994; 34: 507-16.
4. Jordens JZ, Bates J, Griffiths DT. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1994; 34: 515-28.
5. Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105-13.
6. Handwerger S, Raucher B, Altarac D, et al. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin and gentamicin. Clin Infect Dis 1993; 16: 750-5.
7. Murray BE. What can we do about vancomycin-resistant enterococci? Clin Infect Dis 1995; 20: 1134-6.
8. Karanfil LV, Murphy M, Josephson A, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195-200.
9. Rubin LG, Tucci V, Cercenado E, Eliopoulos G, Isenberg HD. Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect Control Hosp Epidemiol 1992; 13: 700-5.
10. Livornese LL Jr., Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112-126.
11. Tedesco F, Markham R, Gurwith M, Christie D, Bartlett JG. Oral vancomycin for antibiotic-associated pseudomembranous colitis. Lancet 1978; 2: 226-8.
12. Baird DR. Comparison of two oral formulations of vancomycin for treatment of diarrhoea associated with Clostridium difficile. J Antimicrob Chemother 1989; 23: 167-9.
13. Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. Ann Intern Med; 117: 297-302.
14. Boyce JM, Opal SM, Chow JW, et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-53.
15. Chadwick PR, Oppenheim BA, Fox A, Woodford N, Morgenstern GR, Scarffe JH. Epidemiology of an outbreak of glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J Hosp Infect 1996; 34 171-82.
16. Chadwick C, Oppenheim BA. Cleaning as a costeffective method of infection control. Lancet 1996; 347: 1776.
17. Chadwick PR, Chadwick CD, Oppenheim BA. Report of a meeting on the epidemiology and control of glycopeptide-resistant enterococci. J Hosp Infect 1996; 33: 83-92.
18. Woodford N, Johnson AP, Morrison D, Speller DCE. Current perspectives on glycopeptide resistance. Clin Microbiol Rev 1995; 8: 585-615.
19. Yamaguchi E, Valena F, Smith SM, Simmons A, Eng RHK. Colonisation pattern of vancomycin-resistant Enterococcus faecium. Am J Infect Control 1994; 22: 202-6.
20. Wade JJ. The emergence of Enterococcus faecium resistant to glycopeptides and other standard agents - a preliminary report. J Hosp Infect 1995; 30(suppl): 483-93.
21. Chadwick PR, Elliot J, Rowland P, Joseph LA, Keaney MGL. Screening patients for glycopeptide-resistant enterococci. J Hosp Infect 1996; 33: 226-8.
22. Edberg SC, Hardalo CJ, Kontnick C, Campbell S. Rapid detection of vancomycin-resistant enterococci. J Clin Microbiol 32; 1994: 2182-4.
23. Chadwick PR, Oppenheim BA. Neomycin blood agar as a selective medium for vancomycin-resistant Enterococcus faecium. J Clin Pathol 1995; 48: 1068-70.
24. Gopal Rao G, Ghanekar K, Ojo F. Selective medium for screening for vancomycin-resistant enterococci in faeces. Eur J Clin Microbiol Infect Dis 1996; 15: 175-7
25. Landman D, Quale JM, Oydna E, et al. Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol 1996; 34: 751-2.
26. Ford M, Perry JD, Gould FK. Use of cephalexin-aztreonamarabinose agar for selective identification of Enterococcus faecium. J Clin Microbiol 1994; 32: 2999-3001.
27. Ford M, Perry JD, Gould FK, Orr KE. Neomycin agar as a selective medium for vancomycin-resistant Enterococcus faecium. J Clin Pathol 1996; 49: 437.
28. Rhinehart E, Smith NE, Wennersten C, et al. Rapid dissemination of a beta-lactamase-producing aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med 1990; 323: 2137-41.
29. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT, Smith SM, Eng RHK. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994; 18: 105-9.
30. Keighley MRB, Burdon DW, Arabi Y. et al. Randomised controlled trial of vancomycin for pseudomembranous colitis and post-operative diarrhoea. Br Med J 1978; 2: 1667-9.
31. Montecalvo MA, Horowitz H, Wormser GP, Seiter K, Carbonaro CA. Effect of novobiocin-containing antimicrobial regimens on infection and colonisation with vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 1995; 39: 794.
32. Wade JJ, Desai N, Casewell MW. Hygenic hand disinfection for the removal of epidemic vancomycin-resistant Enterococcus faecium and gentamicin-resistant Enterobacter cloacae. J Hosp Infect 1991; 18: 211-18.
33. Baillie LWJ, Wade JJ, Casewell MW. Chlorhexidine sensitivity of Enterococcus faecium resistant to vancomycin, high levels of gentamicin, or both. J Hosp Infect 1992; 20: 127-8.
34. Anonymous. Vancomycin resistance in enterococci in hospitals in the United Kingdom. CDR 1995; 50: 281-4.
35. Morrison D, Woodford N, Cookson BD. Epidemic vancomycin-resistant Enterococcus faecium in the UK. Clin Microbiol Infect 1995; 1: 146-7
36. Zervos MJ, Kauffman CA, Therasse PM, Bergman AG, Mikesell TS, Schaberg DR. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med 1987; 106: 687-91.
37. Edmond MB, Ober JF, Weinbaum DL, et al. Vancomycin-resistant Enterococcus faecium bacteraemia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-33.
38. Orr KE, Gould FK, Perry JD, et al. Therapeutic beds: the Trojan horses of the 1990s? Lancet 1994; 344: 65-6.
39. Freeman R, Kearns AM, Lightfoot NF. Heat resistance of nosocomial enterococci. Lancet 1994; 344: 64-5.
40. Panagea S, Chadwick PR. Heat tolerance of vancomycin-resistant Enterococcus faecium. J Clin Pathol 1996; 49: 687-9.
41. Department of Health and Social Security and the Welsh Office. Hospital laundry arrangements for used and infected linen HC (87) 30 London: HMSO, 1987 (renewed until 1993 under letter dated 3 December, 1992).
42. Wilcox MA, Jones BL. Enterococci and hospital laundry. Lancet 1995; 345: 594.
43. British Standards Institution. Washer disinfectors for medical purposes. BS 2745 (Part 2) 1993.
44. Chadwick PR, Oppenheim BA. Vancomycin-resistant enterococci and bedpan washer machines. Lancet 1994; 344: 685